SecBot SecBot
Home › SEC Filings

SEC Filing Analysis

10,000+ reports analyzed by SecBot AI · browse by date or by stock
TickerTypeSentimentImpactSummaryDate
XHLDDEFA14Abearish4/10TEN Holdings convened its 2026 Annual Meeting on October 29, 2026 but failed to achieve a quorum, forcing an adjournmentOct 29, 2026
CDP8-Kbullish6/10COPT Defense Properties reported Q3 2026 FFO per share of $0.71, beating the $0.69 consensus by 2.9% and exceeding the mOct 29, 2026
GBX3neutral2/10Emanuel Pearlman filed a Form 3 initial statement of beneficial ownership with the SEC, reporting zero shares owned in GOct 29, 2026
ULBISC 13D/Aneutral6/10Bradford T. Whitmore and affiliated entities filed Amendment No. 11 to their Schedule 13D, reporting aggregate beneficiaOct 29, 2026
XLABSC 13Gneutral3/10Hack Seed Fund II LP, its general partner Hack Seed Fund II GP LLC, and Alexander Pack filed a Schedule 13G disclosing aOct 29, 2026
SAMG8-Kbearish5/10Silvercrest reported Q3 2026 revenue of $32.7M (+4.5% YoY) and GAAP EPS of $0.08, with adjusted diluted EPS of $0.16. ReOct 29, 2026
BOC8-K/Aneutral4/10Boston Omaha filed this 8-K/A to provide unaudited pro forma financial statements for the completed sale of its General Oct 29, 2026
XHLD8-Kneutral2/10TEN Holdings, Inc. convened its 2026 Annual Meeting of Stockholders on October 29, 2026, but lacked a quorum, so the meeOct 29, 2026
ASUR8-Kbullish6/10Asure Software reported Q3 2026 revenue of $40.0M, up 10% YoY, and a net loss of $0.6M, narrowing from a $5.4M loss a yeOct 29, 2026
CUBI144neutral3/10Jay Sidhu, a director of Customers Bancorp, filed a Form 144 notice of intent to sell 100,000 shares of common stock, wiOct 29, 2026
RHIPRESS-RELEASEneutral2/10Robert Half declared a quarterly cash dividend of $0.59 per share, payable December 15, 2026, to shareholders of record Oct 29, 2026
SDEVPRESS-RELEASEneutral5/10SDEV reported Q3 2026 net income of $50.4M ($0.23 per share), driven by a $58.8M non-cash unrealized gain on SKY tokens Oct 29, 2026
BRZE144neutral2/10Jonathan Hyman, an officer of Braze, filed a Form 144 notice of intent to sell 20,000 shares of common stock with an appOct 29, 2026
MAZE144neutral2/10Atul Dandekar, an officer of Maze Therapeutics, filed a Form 144 notice of intent to sell 15,000 shares of common stock,Oct 29, 2026
SIBN144neutral3/10Michael A. Pisetsky, an officer of SI-BONE, Inc., filed a Form 144 notice of intent to sell 29,665 shares of common stocOct 29, 2026
PRCH144neutral2/10Director Sean Kell filed a Form 144 notice of intent to sell 20,784 shares of Porch Group common stock, with an estimateOct 29, 2026
DAICDEFA14Aneutral5/10CID HoldCo (DAIC) filed this DEFA14A to announce the appointment of Avi Cohen, BladeRanger's designee, to its board of dOct 29, 2026
GLOB6-Kneutral3/10Globant S.A. and its subsidiary Globant, LLC entered into Amendment No. 2 to their Fourth Amended and Restated Credit AgOct 29, 2026
PENG144neutral2/10Anthony Frey, an officer of Penguin Solutions, filed a Form 144 notice of intent to sell 4,631 shares of common stock, vOct 29, 2026
ATEC8-Kbearish5/10ATEC reported Q3 2026 revenue of $221.2M, up 13% YoY but below the $225.1M consensus, with management citing lower bioloOct 29, 2026
LFUS144neutral2/10David Ruppel, an officer of Littelfuse Inc., filed a Form 144 notice of intent to sell 1,493 shares of common stock, witOct 29, 2026
ICE144neutral2/10James Namkung, an officer of Intercontinental Exchange, filed a Form 144 notice of intent to sell 2,430 shares of commonOct 29, 2026
CDZI8-Kbearish5/10Cadiz Inc. entered into a placement agent agreement with Roth Capital Partners to sell 5,000,000 shares at $4.20 per shaOct 29, 2026
INVX8-Kneutral5/10Adjusted EBITDA rose to $55M with a 21% margin. Q4 guidance of $260-$270M revenue and $53-$58M Adjusted EBITDA implies cOct 29, 2026
CRVO8-Kneutral5/10CervoMed announced the publication of two peer-reviewed research articles on neflamapimod for dementia with Lewy bodies Oct 29, 2026
SNDX144neutral2/10Director Dennis Podlesak filed a Form 144 notice of intent to sell 8,000 shares of Syndax Pharmaceuticals common stock, Oct 29, 2026
ANIP144neutral2/10Stephen P. Carey, an officer of ANI Pharmaceuticals, filed a Form 144 notice of intent to sell 8,550 shares of common stOct 29, 2026
CNO8-Kbullish6/10CNO Financial Group reported Q3 2026 net operating income of $179.1M ($1.90 per diluted share), up 47% from $1.29 in Q3 Oct 29, 2026
NBIS144neutral2/10Director John Wilson Boynton IV, through his 2006 trust, filed a Form 144 notice of intent to sell 333 shares of Nebius Oct 29, 2026
WKC8-Kbullish6/10World Kinect reported Q3 2026 adjusted EPS of $0.99, beating the $0.96 consensus, and raised full-year 2026 adjusted EPSOct 29, 2026
« Previous Page 250 of 334 Next »